Drugs / sulfate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02124447 Comparator | Jun → Aug 2014 | — | Medical College of Wisconsin | Withdrawn | No outcome recorded |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2022-09-09 | Lupin Limited | Lupin Launches Generic Suprep® Bowel Prep Kit in the United States lupin.com ↗ |
| 2017-03-03 | Lupin Limited | Lupin Receives FDA Approval for Generic Suprep® Bowel Prep Kit lupin.com ↗ |
| 2016-08-23 | Perrigo Company | Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep® Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso® Gel perrigo.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02124447 ↗ |
| Known as | Suprep | “4. Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution (sulfate): Brand name Suprep” NCT02124447 ↗ |